Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIBerate-Kids OLE: Long-Term Study of Lerodalcibep in Pediatric Patients With HeFH
NCT07775339Phase 3Not yet recruiting
- Sponsor
- LIB Therapeutics
- Start
- Jan 2027
- Primary completion
- Jul 2031
- Countries
- 5
01
Overview
A Phase 3 trial of lerodalcibep in heterozygous familial hypercholesterolemia (HeFH), sponsored by LIB Therapeutics. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
lerodalcibep
03
Conditions
heterozygous familial hypercholesterolemia (HeFH)
Beyond the preview
Go deeper on NCT07775339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07775339.